Congenital ocular colobomas are tissue defects which occur as a result of failure of the ectodermal optic vesicle fissure to close at around 5-7 weeks of fetal life. 1 These defects can affect one or more ocular structures including the iris, ciliary body, lens, retina, choroid, and optic nerve. The incidence of WHO defined blindness (<3/60 best corrected vision in the better eye) has been reported as low as 7% in simple ocular coloboma to 66% in eyes with ocular coloboma and microphthalmos. 2 Most cases are sporadic, but may be familial, in which case autosomal dominant inheritance is most common. Ocular colobomas occur in a variety of chromosomal abnormalities and syndromic disorders. Recently, Williamson et al. identified a heterozygous nonsense mutation in YAP1 in a family with isolated ocular coloboma. 3 We describe a further family with isolated ocular coloboma associated with a YAP1 mutation where there is evidence of incomplete penetrance. This report describes a novel mutation in YAP1 associated with isolated ocular coloboma in a family with an autosomal dominant pattern of inheritance with apparent incomplete penetrance.
Unaffected mutation carriers have been described previously in families with autosomal dominant coloboma including one family with a YAP1 mutation reported by Williamson et al. 3 It is unclear whether this represents true incomplete penetrance or germ line mosaicism. Similar mutation carriers with a normal ocular phenotype have been reported in families with anophthalmos/microphthalmos associated with mutations in OTX2 and SOX 2.
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The YAP (Yes-associated-protein) gene was originally characterized by Sudol et al. who identified a regulatory protein responsible for protein-protein interactions with ubiquitous expression at the RNA level, 6 later shown to be associated with the Hippo signaling pathway responsible for cell contact inhibition integral in the control of organ size during development. 7 Using in situ hybridization and immunohistochemistry, Williamson et al. observed expression of YAP1 in the otic vesicle and future brainstem at 9.5 days postconception which continued as strong expression on the distal optic cup, suggesting that the protein is present in the developing lens and optic stalk. 5 This same group also identified different heterozygous nonsense mutations in YAP1 in a family with isolated ocular coloboma, and in another family with ocular coloboma and variable multisystem involvement (hearing loss, intellectual disability, hematuria, and orofacial clefting). In the first family, apparent non-penetrance was identified in an unaffected carrier similar to the mother in this report. They additionally identified 4 families with heterozygous missense variants in YAP1 all thought to be non-pathogenic. In one family, this was based on non-segregation with disease. In the other 3 families, the identified mutations arose in residues that were not evolutionarily conserved when compared with mouse, chick and zebrafish. Phenylalanine-95 in this study is highly conserved across all 9 species analyzed including mouse, chick and zebrafish (Figure 2 ). This study supports the idea that mutations affecting only the long transcript (those occurring before Met179 of NM_001130145.2) might
give rise to the localized ocular phenotype, while those that affect both long and short transcripts (after Met179) might cause a multi-system disorder.
To date, only two families with coloboma have been reported with mutations in YAP1 gene, a gene with known strong expression in developing ocular structures and known to have a role in cell proliferation during organogenesis. Here, we report a third family with autosomal dominant coloboma with a novel heterozygous mutation in YAP1 and confirm that mutations in this gene may be associated with incomplete penetrance, or germ line mosaicism a well recognized feature of autosomal dominant coloboma.
